Growth Hormone's Effect on the Cardiovascular System
Status:
Terminated
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
To evaluate specific markers of cardiovascular risk before and after growth hormone
replacement therapy in a population of growth hormone deficient adults, as compared to an
age, gender, and BMI-matched healthy population.
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center
Collaborators:
National Center for Research Resources (NCRR) Pfizer